Drug Induced Hypersensitivity Syndrome Secondary to Phenobarbitone
Author(s) -
Syed Zia Inamdar,
Seema Jakanur,
Pradeepthi Katragadda,
Ajit B Janagond,
Mallinath V Paramagond,
Raghavendra V. Kulkarni,
Akram Naikwadi,
Ananth Koth,
Arvind Patil
Publication year - 2020
Publication title -
indian journal of pharmacy practice
Language(s) - English
Resource type - Journals
ISSN - 0974-8326
DOI - 10.5530/ijopp.13.3.48
Subject(s) - medicine , drug , dermatology , delayed hypersensitivity , pharmacology , immunology , antigen
Phenobarbitonea barbiturate, non-selective central nervous system depressant drug, primarily used as a sedative hypnotic and anticonvulsant in sub hypnotic doses. It has long term anticonvulsant effect, used in the treatment of generalized tonic-clonic and cortical local seizures. It is also effective in acute convulsive episodes associated with status epileptic’s cholera, eclampsia, meningitis, tetanus and toxic reactions to strychnine or local anesthetics. The present case report describes the occurrence of anticonvulsant drug induced hypersensitivity drug reaction followed after to the use of phenobarbitone in a pediatric patient prescribed to treat his seizure disorder. The suspected drug was immediately stopped and the patient was managed symptomatically. The causality assessment of the adverse effect revealed a “probable” causal relationship for the suspected drug and reaction was categorized as “moderately severe” in nature.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom